|
Volumn , Issue , 2014, Pages e37-e42
|
Optimizing chemotherapy in triple-negative breast cancer: the role of platinum
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
PLATINUM DERIVATIVE;
TRANSCRIPTOME;
CANCER STAGING;
DNA REPAIR-DEFICIENCY DISORDERS;
FEMALE;
GENETICS;
HUMAN;
MOLECULARLY TARGETED THERAPY;
PATHOLOGY;
PERSONALIZED MEDICINE;
PROCEDURES;
TRIPLE NEGATIVE BREAST NEOPLASMS;
TUMOR SUPPRESSOR GENE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DNA REPAIR-DEFICIENCY DISORDERS;
FEMALE;
GENES, BRCA1;
GENES, BRCA2;
HUMANS;
MOLECULAR TARGETED THERAPY;
NEOPLASM STAGING;
PLATINUM COMPOUNDS;
PRECISION MEDICINE;
TRANSCRIPTOME;
TRIPLE NEGATIVE BREAST NEOPLASMS;
|
EID: 84964698044
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.14694/EdBook_AM.2014.34.e37 Document Type: Review |
Times cited : (20)
|
References (0)
|